How many clinical trials are studying Nivolumab & Ipilimumab?

3 recruiting trials in our tracked data involve Nivolumab & Ipilimumab.

What conditions is Nivolumab & Ipilimumab being studied for?

In our tracked recruiting trials, Nivolumab & Ipilimumab is being studied in trials for Melanoma, Lung Cancer - Non Small Cell, Lung cancer.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 1 1 Phase 2 1 Phase 3 1

Condition	Trials
Melanoma	2
Lung Cancer - Non Small Cell	1
Lung cancer	1
Malignant Melanoma Stage III	1
Uveal Melanoma	1

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
NCT07501117 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3)
NCT06926790 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma
NCT06794775 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations